SPONTANEOUS REGRESSION OF HUMAN-MELANOMA NONMELANOMA SKIN-CANCER - ASSOCIATION WITH INFILTRATING CD4(+) T-CELLS

被引:115
作者
HALLIDAY, GM
PATEL, A
HUNT, MJ
TEFANY, FJ
BARNETSON, RSC
机构
[1] Department of Dermatology, University of Sydney, Royal Prince Alfred Hospital, Camperdown, 2050, New South Wales, Missenden Road
关键词
D O I
10.1007/BF00299157
中图分类号
R61 [外科手术学];
学科分类号
摘要
Spontaneous regression occurs in some human malignant melanomas and basal cell carcinomas (BCCs). We have compared the cellular infiltrate in regressing and nonregressing tumors in order to analyze the mechanism by which regression occurs. Regressing primary melanomas and BCCs were infiltrated with a larger number of CD4(+), but not CD8(+) T lymphocytes than were seen in nonregressing tumors. The number of interleukin 2 receptor-positive (early activation marker) but not transferrin receptor-positive (intermediate activation marker)T cells was increased, indicating that the infiltrating T cells were activated. Large numbers of Langerhans cells, macrophages, and other class II major histocompatibility complex (MHC)-expressing cells were present but were not increased in the regressing tumors. There were no detectable B lymphocytes, and the regressing tumor cells displayed levels of HLA-DR expression similar to those of the nonregressing tumors. Comparison of squamous cell carcinoma (SCCs) with keratoacanthomas (KAs), which are likely to be a spontaneously regressing form of SCC, also showed increased infiltration of activated CD4(+), but not CD8(+), T cells within the KA. A murine ultraviolet (UV)-induced squamous tumor that spontaneously regresses when transplanted into immunocompetent syngeneic mice was also infiltrated with increased numbers of activated CD4(+), but not CD8(+), T cells prior to and during rejection. These results indicate that spontaneous regression of human skin tumors is likely to be immunologically mediated, and that CD4(+) T lymphocytes seem to mediate this regression.
引用
收藏
页码:352 / 358
页数:7
相关论文
共 45 条
[1]   ISOLATION OF THE THROMBOSPONDIN MEMBRANE-RECEPTOR [J].
ASCH, AS ;
BARNWELL, J ;
SILVERSTEIN, RL ;
NACHMAN, RL .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (04) :1054-1061
[2]   ALTERATIONS IN LANGERHANS CELLS DURING GROWTH OF TRANSPLANTABLE MURINE TUMORS [J].
BERGFELT, L ;
BUCANA, C ;
KRIPKE, ML .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1988, 91 (02) :129-135
[3]   TRANSIENT EXPRESSION OF INTERLEUKIN-2 RECEPTORS - CONSEQUENCES FOR T-CELL GROWTH [J].
CANTRELL, DA ;
SMITH, KA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (06) :1895-1911
[4]   INTRALESIONAL INTERFERON THERAPY FOR BASAL-CELL CARCINOMA [J].
CORNELL, RC ;
GREENWAY, HT ;
TUCKER, SB ;
EDWARDS, L ;
ASHWORTH, S ;
VANCE, JC ;
TANNER, DJ ;
TAYLOR, EL ;
SMILES, KA ;
PEETS, EA .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990, 23 (04) :694-700
[5]  
CURSON C, 1979, J CUTAN PATHOL, V6, P432, DOI 10.1111/j.1600-0560.1979.tb01166.x
[6]   IMMUNOGENICITY AND CROSS-REACTIVITY OF SYNGENEIC MURINE MELANOMAS [J].
DONAWHO, C ;
KRIPKE, ML .
CANCER COMMUNICATIONS, 1990, 2 (03) :101-107
[7]   VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY [J].
DRANOFF, G ;
JAFFEE, E ;
LAZENBY, A ;
GOLUMBEK, P ;
LEVITSKY, H ;
BROSE, K ;
JACKSON, V ;
HAMADA, H ;
PARDOLL, D ;
MULLIGAN, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3539-3543
[8]  
FERRADINI L, 1992, CANCER RES, V52, P4649
[9]   ANALYSIS OF T-CELL RECEPTOR VARIABILITY IN TUMOR-INFILTRATING LYMPHOCYTES FROM A HUMAN REGRESSIVE MELANOMA - EVIDENCE FOR INSITU T-CELL CLONAL EXPANSION [J].
FERRADINI, L ;
MACKENSEN, A ;
GENEVEE, C ;
BOSQ, J ;
DUVILLARD, P ;
AVRIL, MF ;
HERCEND, T .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :1183-1190
[10]  
GRABBE S, 1991, J IMMUNOL, V146, P3656